Previous studies have demonstrated that ITGA4 is hypermethylated in inflamed colon tissue/colitis, and that the treatment of anti-ITGA4 antibodies further aggravate colitis by IL-1β, TNF-α, and IFN-γ recruitment [53]. The gene discussed is TNF; the disease is colitis.